These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30115763)

  • 1. Heterogeneous dopamine signals support distinct features of motivated actions: implications for learning and addiction.
    Saddoris MP; Siletti KA; Stansfield KJ; Bercum MF
    Learn Mem; 2018 Sep; 25(9):416-424. PubMed ID: 30115763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
    Jentsch JD; Roth RH; Taylor JR
    Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History.
    Illenberger JM; Harrod SB; Mactutus CF; McLaurin KA; Kallianpur A; Booze RM
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):715-728. PubMed ID: 32533296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novelty Seeking and Drug Addiction in Humans and Animals: From Behavior to Molecules.
    Wingo T; Nesil T; Choi JS; Li MD
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):456-70. PubMed ID: 26481371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasticity of addiction: a mesolimbic dopamine short-circuit?
    Niehaus JL; Cruz-Bermudez ND; Kauer JA
    Am J Addict; 2009; 18(4):259-71. PubMed ID: 19444729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling.
    Levy KA; Brodnik ZD; Shaw JK; Perrey DA; Zhang Y; España RA
    Psychopharmacology (Berl); 2017 Sep; 234(18):2761-2776. PubMed ID: 28667509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging dopamine's role in drug abuse and addiction.
    Volkow ND; Fowler JS; Wang GJ; Baler R; Telang F
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):3-8. PubMed ID: 18617195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research.
    Ritz MC; Kuhar MJ
    Biochem Soc Symp; 1993; 59():51-64. PubMed ID: 7910741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
    Pierce RC; Kumaresan V
    Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. There and back again: a tale of norepinephrine and drug addiction.
    Weinshenker D; Schroeder JP
    Neuropsychopharmacology; 2007 Jul; 32(7):1433-51. PubMed ID: 17164822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications.
    Volkow ND; Fowler JS; Wang GJ; Swanson JM; Telang F
    Arch Neurol; 2007 Nov; 64(11):1575-9. PubMed ID: 17998440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid and nondopamine reward circuitry and state-dependent mechanisms.
    Fujita M; Ide S; Ikeda K
    Ann N Y Acad Sci; 2019 Sep; 1451(1):29-41. PubMed ID: 29512887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic system activity under stress condition - seeking individual differences, preclinical studies.
    Gryz M; Lehner M; Wisłowska-Stanek A; Płaźnik A
    Psychiatr Pol; 2018 Jun; 52(3):459-470. PubMed ID: 30218562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications.
    Volkow ND; Fowler JS; Wang GJ; Swanson JM
    Mol Psychiatry; 2004 Jun; 9(6):557-69. PubMed ID: 15098002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse.
    Zocchi A; Girlanda E; Varnier G; Sartori I; Zanetti L; Wildish GA; Lennon M; Mugnaini M; Heidbreder CA
    Synapse; 2003 Dec; 50(4):293-302. PubMed ID: 14556234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic probing of dopamine receptors in drug addiction.
    Xu M; Zhang J
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):703-8. PubMed ID: 15503872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use.
    Di Chiara G
    J Psychopharmacol; 1998; 12(1):54-67. PubMed ID: 9584969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: areas of agreement, disagreement, and implications for addiction.
    Bradberry CW
    Psychopharmacology (Berl); 2007 Apr; 191(3):705-17. PubMed ID: 17031707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits.
    Bisagno V; González B; Urbano FJ
    Pharmacol Res; 2016 Jul; 109():108-18. PubMed ID: 26826399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.